Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Duloxetine in Knee Osteoarthritis
IRCT20230821059204N1Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of duloxetine in knee osteoarthritis (OA), sponsored by Mazandaran University of Medical Sciences. Started Oct 2023; status: completed.
02
Drugs
duloxetine
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on IRCT20230821059204N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230821059204N1.